Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
Holding OTLC?
Track your performance easily
OTLC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.05
Previous Close$0.03
Volume187.31K
Average Volume (3M)357.88K
Market Cap
$12.13M
Enterprise Value$11.41M
Total Cash (Recent Filing)$72.22K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Nov 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,270,315
10 Day Avg. Volume275,512
30 Day Avg. Volume357,881
Standard Deviation0.21
R-Squared0.00493
Alpha-0.00927
Financial Highlights & Ratios
Price to Book (P/B)1.00
Price to Sales (P/S)179.92
Price to Cash Flow (P/CF)-12.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue162.97
Enterprise Value/Gross Profit162.97
Enterprise Value/Ebitda-696.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncotelic Therapeutics News
PremiumCompany Announcements
Oncotelic Therapeutics Secures Funds Through Equity Sales
PremiumCompany Announcements
Oncotelic Therapeutics Strikes Material Definitive Legal AgreementOwnership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OTLC FAQ
What was Oncotelic Therapeutics’s price range in the past 12 months?
Oncotelic Therapeutics lowest stock price was $0.02 and its highest was $0.04 in the past 12 months.
What is Oncotelic Therapeutics’s market cap?
Currently, no data Available
When is Oncotelic Therapeutics’s upcoming earnings report date?
Oncotelic Therapeutics’s upcoming earnings report date is Nov 18, 2024 which is in 4 days.
How were Oncotelic Therapeutics’s earnings last quarter?
Oncotelic Therapeutics released its earnings results on Aug 15, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Oncotelic Therapeutics overvalued?
According to Wall Street analysts Oncotelic Therapeutics’s price is currently Overvalued.
Does Oncotelic Therapeutics pay dividends?
Oncotelic Therapeutics does not currently pay dividends.
What is Oncotelic Therapeutics’s EPS estimate?
Oncotelic Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncotelic Therapeutics have?
Oncotelic Therapeutics has 406,270,320 shares outstanding.
What happened to Oncotelic Therapeutics’s price movement after its last earnings report?
Oncotelic Therapeutics reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Oncotelic Therapeutics?
Currently, no hedge funds are holding shares in OTLC
---
Oncotelic Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.40%
12-Months-Change
Fundamentals
Return on Equity
-10.13%
Trailing 12-Months
Asset Growth
-0.26%
Trailing 12-Months
Company Description
Oncotelic Therapeutics
Mateon Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development investigational drugs for the treatment of orphan oncology indications. Its product pipeline includes CA4P and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, CA.
---
Technical Analysis
---